MediFind

Find a Doctor

Joel M. Baumgartner

Regents Of The Univesity Of California - Ucsd Medical Group
Surgical Oncology, General Surgery
Male
Practicing approx. 17 years

Bio


Joel Baumgartner is a Surgical Oncologist and a General Surgeon in La Jolla, California. He has been an author on 51 peer reviewed articles and participated in 1 clinical trials in the past 15 years. Dr. Baumgartner's top three areas of expertise are Pseudomyxoma Peritonei, Melanoma, and Colorectal Cancer. He is licensed to treat patients in CA.

Contact

3855 Health Sciences Dr
La Jolla, CA 92093, US

Latest Research


Latest Advance
Study
  • Condition: Malignant Bowel Obstruction with Appendiceal Cancer
  • Journal: Annals of surgical oncology
  • Treatment Used: Surgical Intervention
  • Number of Patients: 26
  • Published —
This study tested the safety and efficacy of using a surgical intervention to treat patients with malignant bowel obstruction that they acquired from appendiceal cancer.
Latest Advance
Study
  • Condition: Post-Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Journal: Annals of surgical oncology
  • Treatment Used: Pharmacothromboprophylaxis Strategies for Venous Thromboembolism (VTE)
  • Number of Patients: 0
  • Published —
This study characterized the incidence, risk factors, and pharmacothromboprophylaxis (prevention of clots) strategies for venous thromboembolism (clot; VTE) after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).
Latest Advance
Study
  • Condition: Metastatic Colon Cancer
  • Journal: Annals of surgical oncology
  • Treatment Used: Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Number of Patients: 115
  • Published —
This study evaluated the impact of sidedness on prognosis in peritoneal-only colon cancer metastases treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Latest Advance
Study
  • Condition: Peritoneal Metastases (PM) From a Small Bowel Adenocarcinoma (SBA)
  • Journal: Annals of surgical oncology
  • Treatment Used: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy
  • Number of Patients: 152
  • Published —
This study evaluated the outcome after cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases (PM) from small bowel adenocarcinoma (SBA).

Contact

3855 Health Sciences Dr
La Jolla, CA 92093, US

Affiliations

  • Uc San Diego Health Hillcrest - Hillcrest Med Ctr

Credentials

  • Graduate InstitutionIndiana University School Of Medicine
    2003
  • Licenses
    Surgery in CA
  • Board Certifications
    Surgical Oncology
    General Surgery

Insurance

Contact them to find out if they accept your insurance plan.